WHY NORTH BUD FARMS INC?
- Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening in 2019
As shown in other legal jurisdictions (Colorado, Washington, Nevada, California) - Infused products sector has become the highest margin segment of the industry
- Positioned to be a raw input producer for this space
- Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
THE OPPORTUNITY
- Acquired late stage ACMPR applicant GrowPros
MMP from Tetra Bio-Pharma (TSXV: TBP) - GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
- Phase 1 is located on 95 acres of agricultural farmland in Low, Québec.
- Option exists to acquire more land if needed
- Facility will focus on GMP (higher production grade) pharma-grade cultivation and food-grade extracted inputs
LOCATION
SITE DETAILS: LOW COST INFRASTRUCTURE
POSITIONED FOR LEGALIZATION 2.0
- First mover advantage often becomes first-mover disadvantage
Examples: AOL, Netscape, Yahoo, BlackBerry - Second mover advantage: clearer picture of market and competition
Examples: Google, Facebook, Amazon, Apple, NORTHBUD
STRATEGIC VERTICALS
Pharma Development
- North Bud will focus on GMP standardized production to be used by our pharma commercialization partners i.e. Tetra Bio-Pharma We will focus on securing unique strains containing high amounts of specific cannabinoids not typically found in recreational cannabis.
Food Grade Inputs
-
- Using our licensed encapsulation technology we will
engage existing food and beverage companies looking
to develop product lines containing cannabis.
- Using our licensed encapsulation technology we will
Tags: #smallcapstocks, $TSXV, Cannabinoid, CSE, Hemp, MMJ